Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics & health. Browse all Genetics & Health education

Retinitis pigmentosa (RP) is a group of inherited eye conditions that gradually break down the light-sensing cells of the retina, typically causing night blindness and shrinking peripheral vision first. Because RP is fundamentally genetic, understanding the genes involved is central to making sense of a diagnosis, discussing risk within a family, and planning care conversations with an eye specialist.

What retinitis pigmentosa is

RP describes a family of retinal dystrophies in which photoreceptors — the rod and cone cells that convert light into nerve signals — progressively lose function. Rods usually decline first, which is why difficulty seeing in dim light and loss of side vision are early hallmarks. Progression varies widely: some people notice symptoms in childhood, others not until mid-adulthood. RP affects roughly 1 in 3,500 to 1 in 4,000 people worldwide, making it one of the more common inherited causes of vision loss.

Why RP is fundamentally a genetic condition

More than 70 genes have been linked to non-syndromic RP, and the condition can be inherited in autosomal dominant, autosomal recessive, or X-linked patterns. That genetic diversity is why two people with the same clinical label can have very different courses. Identifying the specific gene involved is done through dedicated clinical genetic testing ordered by an ophthalmologist or genetic counselor — a targeted diagnostic process distinct from general wellness genetics.

Key genes: RHO, USH2A, and RPGR

A handful of genes account for a large share of RP cases. RHO encodes rhodopsin, the light-sensitive pigment in rod cells, and RHO variants are a leading cause of autosomal dominant RP. USH2A is a frequent cause of autosomal recessive RP and of Usher syndrome, where RP occurs alongside hearing loss. RPGR drives most X-linked RP, which tends to affect males more severely. Naming the gene matters because it shapes inheritance risk for relatives and eligibility for gene-specific research and clinical trials.

How genetic information supports care conversations

Knowing the underlying gene does not by itself change vision, but it informs several practical decisions: family planning and cascade testing for relatives, prognosis discussions, and access to emerging gene-specific therapies and trials, some of which are approved only for particular genotypes. An ophthalmologist and a genetic counselor are the right partners for confirming a diagnosis and interpreting clinical results. This is a medical process — not something a general wellness test replaces.

Living with RP: evidence-based support

Care for RP focuses on preserving function and quality of life. Low-vision aids, orientation and mobility training, adequate lighting, UV-protective eyewear, and regular monitoring are commonly recommended by specialists. Some clinicians discuss vitamin A strategies or specific therapies in selected cases — decisions that belong with your eye doctor, because they depend on genotype and individual factors. The goal is a plan built around your specific diagnosis, not a generic protocol.

Where pathway-level genetic insight fits

General wellness genetics and clinical RP testing serve different purposes. The Precision Peptide Genetic Test looks at 14 pathways, 49 peptides, 150+ genetic insights across broad biological pathways; it is educational and does not diagnose retinitis pigmentosa, detect RP-causing mutations, or replace an ophthalmologist's clinical genetic panel. If RP is suspected, dedicated diagnostic testing through an eye specialist is the appropriate path. Pathway-level insight simply helps you engage more knowledgeably with your broader health.

Frequently Asked Questions

Is retinitis pigmentosa always inherited?

RP is a genetic condition, and most cases are inherited through autosomal dominant, autosomal recessive, or X-linked patterns involving genes like RHO, USH2A, and RPGR. Occasionally no family history is apparent, but the underlying cause is still a gene variant. A genetic counselor can clarify inheritance for your family.

Can genetic testing diagnose retinitis pigmentosa?

Clinical genetic testing ordered by an ophthalmologist or genetic counselor can identify the specific gene behind RP and confirm a diagnosis made through eye exams. General wellness genetic tests, including the Precision Peptide Genetic Test, are educational and do not diagnose RP or detect its causative mutations.

How is retinitis pigmentosa managed?

There is no single cure, so specialists focus on preserving function with low-vision aids, mobility training, protective eyewear, and regular monitoring. Gene-specific therapies and trials exist for certain genotypes. Management decisions, including any vitamin or treatment strategy, should be made with your ophthalmologist based on your specific diagnosis.

Want broad pathway-level context for your health picture? Take the Precision Peptide Genetic Test to explore your peptide-pathway genetics at the pathway level — the test tells you about your biology, not what to put in your body.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves